No breast?

No problem. This data review of prospective trials spanning back to the 1997 reporting of the British Columbia trial points to hypofractionation over 3-4 weeks being a safe and effective treatment option for post-mastectomy radiation that, just as has been the case in the UK for years, may soon become the new standard in the US. | Sayan, Adv Radiat Oncol 2021


Popular Posts